{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:51:15Z","timestamp":1758819075333},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Calabresi Scholar Award","award":["K12 CA088084 K12"],"award-info":[{"award-number":["K12 CA088084 K12"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["2P50 CA098258-06","2P50CA083639"],"award-info":[{"award-number":["2P50 CA098258-06","2P50CA083639"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NCI","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ygyno.2016.01.021","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T01:06:28Z","timestamp":1453511188000},"page":"377-380","source":"Crossref","is-referenced-by-count":2,"title":["The European Society of Gynecologic Oncology (ESGO) 19th biannual meeting: Overview and summary of selected topics"],"prefix":"10.1016","volume":"140","author":[{"given":"Shannon N.","family":"Westin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2016.01.021_bb0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2016.01.021_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/95.2.125","article-title":"International collaborative ovarian neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer","volume":"95","author":"Colombo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"19","key":"10.1016\/j.ygyno.2016.01.021_bb0015","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","article-title":"Pediatric outcome after maternal cancer diagnosed during pregnancy","volume":"373","author":"Amant","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2016.01.021_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju048","article-title":"Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples","volume":"106","author":"Riester","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.ygyno.2016.01.021_bb0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2016.01.021_bb0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2015.35","article-title":"Just how accurate are the major risk stratification systems for early-stage endometrial cancer?","volume":"112","author":"Bendifallah","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"9213","key":"10.1016\/j.ygyno.2016.01.021_bb0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2016.01.021_bb0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"9721","key":"10.1016\/j.ygyno.2016.01.021_bb0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","article-title":"Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis","volume":"375","author":"Todo","year":"2010","journal-title":"Lancet"},{"issue":"Suppl. 6","key":"10.1016\/j.ygyno.2016.01.021_bb0050","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2016.01.021_bb0055","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1038\/bjc.2014.237","article-title":"A clue towards improving the European society of medical oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion","volume":"110","author":"Bendifallah","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2016.01.021_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/02656736.2012.673047","article-title":"Long-term survival data of triple modality treatment of stage IIB\u2013III\u2013IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia \u2014 an update","volume":"28","author":"Westermann","year":"2012","journal-title":"Int. J. Hyperth."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T01:47:28Z","timestamp":1620784048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0090825816000408"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.01.021","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}